Literature DB >> 2445074

FK-506 enhances cyclosporine uptake by peripheral blood lymphocytes.

A Sanghvi1, V Warty, A Zeevi, W Diven, R Duquesnoy, L Makowka, T E Starzl.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2445074      PMCID： PMC3005272     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  11 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  An improved rosetting assay for detection of human T lymphocytes.

Authors:  M E Kaplan; C Clark
Journal:  J Immunol Methods       Date:  1974-07       Impact factor: 2.303

3.  Differences in the binding, internalization and catabolism of low-density lipoprotein between normal human T and B lymphocytes.

Authors:  A Sanghvi; V Warty
Journal:  Biochem J       Date:  1985-04-15       Impact factor: 3.857

4.  The transport of cyclosporine in association with plasma lipoproteins in heart and liver transplant patients.

Authors:  J Gurecki; V Warty; A Sanghvi
Journal:  Transplant Proc       Date:  1985-08       Impact factor: 1.066

5.  Depletion of monocytes from human peripheral blood mononuclear leukocytes: comparison of the sephadex G-10 column method with other commonly used techniques.

Authors:  T R Jerrells; J H Dean; G L Richardson; R B Herberman
Journal:  J Immunol Methods       Date:  1980       Impact factor: 2.303

6.  Kinetics of uptake and intracellular binding of Cyclosporine A in RAJI cells, in vitro.

Authors:  I Fabre; G Fabre; N Lena; J P Cano
Journal:  Biochem Pharmacol       Date:  1986-12-01       Impact factor: 5.858

7.  Cyclophilin: a specific cytosolic binding protein for cyclosporin A.

Authors:  R E Handschumacher; M W Harding; J Rice; R J Drugge; D W Speicher
Journal:  Science       Date:  1984-11-02       Impact factor: 47.728

8.  Binding and degradation of low density lipoproteins by cultured human fibroblasts. Comparison of cells from a normal subject and from a patient with homozygous familial hypercholesterolemia.

Authors:  J L Goldstein; M S Brown
Journal:  J Biol Chem       Date:  1974-08-25       Impact factor: 5.157

9.  Cyclosporin A binding to calmodulin: a possible site of action on T lymphocytes.

Authors:  P M Colombani; A Robb; A D Hess
Journal:  Science       Date:  1985-04-19       Impact factor: 47.728

10.  Defective internalization of low density lipoprotein in epidermoid cervical cancer cells.

Authors:  D Gal; E R Simpson; J C Porter; J M Snyder
Journal:  J Cell Biol       Date:  1982-03       Impact factor: 10.539
View more
  7 in total

1.  Species differences in sensitivity of T lymphocytes to immunosuppressive effects of FK 506.

Authors:  G Eiras; O Imventarza; N Murase; Y Ueda; S Todo; T Starzl; R J Duquesnoy; A Zeevi
Journal:  Transplantation       Date:  1990-06       Impact factor: 4.939

2.  In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs.

Authors:  A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1988-02-01       Impact factor: 1.066

3.  FK506: a novel immunosuppressive agent. Characteristics of binding and uptake by human lymphocytes.

Authors:  V Warty; W Diven; E Cadoff; S Todo; T Starzl; A Sanghvi
Journal:  Transplantation       Date:  1988-09       Impact factor: 4.939

4.  Immunosuppressive effect of cyclosporine metabolites from human bile on alloreactive T cells.

Authors:  A Zeevi; G Eiras; G Burckart; L Makowka; R Venkataramanan; C P Wang; D H Van Thiel; N Murase; T E Starzl; R Duquesnoy
Journal:  Transplant Proc       Date:  1988-04       Impact factor: 1.066

5.  Immunosuppressive activity of FK-506 in rats: flow cytometric analysis of lymphocyte populations in blood, spleen and thymus during treatment and following drug withdrawal.

Authors:  J Woo; C S Ross; J I Milton; A W Thomson
Journal:  Clin Exp Immunol       Date:  1990-01       Impact factor: 4.330

6.  Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction.

Authors:  S Todo; Y Ueda; J A Demetris; O Imventarza; M Nalesnik; R Venkataramanan; L Makowka; T E Starzl
Journal:  Surgery       Date:  1988-08       Impact factor: 3.982

Review 7.  Review of the early diagnoses and assessment of rejection in vascularized composite allotransplantation.

Authors:  Ravi Starzl; Gerald Brandacher; W P Andrew Lee; Jaime Carbonell; Wensheng Zhang; Jonas Schnider; Vijay Gorantla; Stefan Schneeberger; Xin Xiao Zheng
Journal:  Clin Dev Immunol       Date:  2013-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.